You are accessing a medical content website
Are you a health professional?

Revista Española de Cardiología (English Edition) Revista Española de Cardiología (English Edition)
Rev Esp Cardiol. 2017;70:905-6 - Vol. 70 Num.11 DOI: 10.1016/j.rec.2017.05.026

Circulating Amyloid-Beta (1-40) Predicts Clinical Outcomes in Patients With Heart Failure

Kimon Stamatelopoulos a, Konstantinos Stellos b,c,d,

a Department of Clinical Therapeutics. Alexandra Hospital, University of Athens, Athens, Greece
b Department of Cardiology, Center of Internal Medicine, Goethe University Frankfurt, Frankfurt, Germany
c German Center of Cardiovascular Research (Deutsches Zentrum für Herz-Kreislaufforschung, DZHK), Rhein-Main Partner Site, Frankfurt, Germany
d Institute of Cardiovascular Regeneration, Center of Molecular Medicine, Goethe University Frankfurt, Frankfurt, Germany

Refers to

Bloodstream Amyloid-beta (1-40) Peptide, Cognition, and Outcomes in Heart Failure  Only available in Spanish
Antoni Bayes-Genis, Jaume Barallat, Marta de Antonio, Mar Domingo, Elisabet Zamora, Joan Vila, Isaac Subirana, Paloma Gastelurrutia, M. Cruz Pastor, James L. Januzzi, Josep Lupón
Rev Esp Cardiol. 2017;70:924-32
Abstract - Full text - PDF


You can access the full text of this article:

Members of the Spanish Society of Cardiology

Subscribers of Revista Española de Cardiología

You may purchase this article for 30.00 €

Buy Now
Subscribers of ScienceDirect

1885-5857/© 2017 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved